GlassScriptPhysician profile
Emily Anne Jenson
NPI 1932641594
$3,971.15
in general payments reported to CMS, 2019-2025
21 companies · $648 in 2025
The $648 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $1,016 · 2023: $1,007 · 2024: $865 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.90 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.06 | 2021-2025 | |
| Janssen Biotech, INC. | $497.04 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $277.60 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $264.01 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $260.95 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $227.77 | 2022-2025 | Blu-U, Odomzo |
| Amgen INC. | $221.06 | 2021-2025 | Otezla, Otezla, Enbrel |
| Pfizer INC. | $210.78 | 2022-2025 | |
| Dermavant Sciences, INC. | $148.66 | 2023-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $135.74 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $101.35 | 2022-2025 | Nemluvio |
| Ucb, INC. | $88.53 | 2021-2023 | Cimzia |
| Lilly USA, LLC | $80.32 | 2021-2022 | |
| Inari Medical, INC. | $79.47 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Incyte Corporation | $79.12 | 2022-2025 | Opzelura |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $66.13 | 2022-2023 | Klisyri |
| Arcutis Biotherapeutics, INC. | $45.57 | 2024-2025 | Zoryve |
| Organon LLC | $41.73 | 2025 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $15.10 | 2025 | Valchlor |
| Oxford Immunotec USA INC | $13.74 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Jenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.